Fentanyl Drug Finds New Home in First Opioid Crisis Bankruptcy Deal

Insys Therapeutics won bankruptcy-court approval to sell Subsys, the opioid that spawned criminal racketeering charges against its top executives and set off investigations and lawsuits that plunged the company into bankruptcy.